Malignant mesothelioma (MM) is an aggressive type of tumour causing high mortality. One reason for this paradigm may be the existence of a subpopulation of tumour-initiating cells (TICs) that endow MM with drug resistance and recurrence. The objective of this study was to identify and characterise a TIC subpopulation in MM cells, using spheroid cultures, mesospheres, as a model of MM TICs. Mesospheres, typified by the stemness markers CD24, ABCG2 and OCT4, initiated tumours in immunodeficient mice more efficiently than adherent cells. CD24 knock-down cells lost the sphere-forming capacity and featured lower tumorigenicity. Upon serial transplantation, mesospheres were gradually more efficiently tumrigenic with increased level of stem cell markers. We also show that mesospheres feature mitochondrial and metabolic properties similar to those of normal and cancer stem cells. Finally, we show that mesothelioma-initiating cells are highly susceptible to mitochondrially targeted vitamin E succinate. This study documents that mesospheres can be used as a plausible model of mesothelioma-initiating cells and that they can be utilised in the search for efficient agents against MM.

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Department of Molecular and Clinical Sciences Polytechnic University of Marche Ancona Italy

Institute of Biotechnology Academy of Sciences of the Czech Republic Prague Czech Republic

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

School of Medical Science Griffith University Southport Queensland Australia

000      

00000naa a2200000 a 4500

001      

bmc16010243

003      

CZ-PrNML

005      

20231121141123.0

007      

ta

008      

160408s2015 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1371/journal.pone.0119549 $2 doi

024    7_

$a 10.1371/journal.pone.0119549 $2 doi

035    __

$a (PubMed)25932953

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Pasdar, Elham Alizadeh $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

245    10

$a Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents / $c EA. Pasdar, M. Smits, M. Stapelberg, M. Bajzikova, M. Stantic, J. Goodwin, B. Yan, J. Stursa, J. Kovarova, K. Sachaphibulkij, A. Bezawork-Geleta, M. Sobol, A. Filimonenko, M. Tomasetti, R. Zobalova, P. Hozak, LF. Dong, J. Neuzil,

520    9_

$a Malignant mesothelioma (MM) is an aggressive type of tumour causing high mortality. One reason for this paradigm may be the existence of a subpopulation of tumour-initiating cells (TICs) that endow MM with drug resistance and recurrence. The objective of this study was to identify and characterise a TIC subpopulation in MM cells, using spheroid cultures, mesospheres, as a model of MM TICs. Mesospheres, typified by the stemness markers CD24, ABCG2 and OCT4, initiated tumours in immunodeficient mice more efficiently than adherent cells. CD24 knock-down cells lost the sphere-forming capacity and featured lower tumorigenicity. Upon serial transplantation, mesospheres were gradually more efficiently tumrigenic with increased level of stem cell markers. We also show that mesospheres feature mitochondrial and metabolic properties similar to those of normal and cancer stem cells. Finally, we show that mesothelioma-initiating cells are highly susceptible to mitochondrially targeted vitamin E succinate. This study documents that mesospheres can be used as a plausible model of mesothelioma-initiating cells and that they can be utilised in the search for efficient agents against MM.

650    _2

$a zvířata $7 D000818

650    _2

$a antigen CD24 $x metabolismus $7 D051927

650    _2

$a antitumorózní látky $x farmakologie $7 D000970

650    _2

$a nádorové biomarkery $x metabolismus $7 D014408

650    _2

$a buněčná adheze $x účinky léků $7 D002448

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a proliferace buněk $x účinky léků $7 D049109

650    _2

$a progrese nemoci $7 D018450

650    _2

$a genový knockdown $7 D055785

650    _2

$a lidé $7 D006801

650    _2

$a inhibiční koncentrace 50 $7 D020128

650    _2

$a nádory plic $x metabolismus $x patologie $7 D008175

650    _2

$a mezoteliom $x metabolismus $x patologie $7 D008654

650    _2

$a myši nahé $7 D008819

650    _2

$a mitochondrie $x účinky léků $x metabolismus $7 D008928

650    _2

$a invazivní růst nádoru $7 D009361

650    _2

$a transplantace nádorů $7 D009368

650    _2

$a nádorové kmenové buňky $x účinky léků $x metabolismus $x patologie $7 D014411

650    _2

$a fenotyp $7 D010641

650    _2

$a buněčné sféroidy $x účinky léků $x patologie $7 D018874

650    _2

$a tokoferoly $x farmakologie $7 D024505

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Smits, Michael $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Stapelberg, Michael $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Bajzikova, Martina $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

700    1_

$a Stantic, Marina $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Goodwin, Jacob $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Yan, Bing $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Štursa, Jan $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. $7 xx0247183

700    1_

$a Kovarova, Jaromira $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

700    1_

$a Sachaphibulkij, Karishma $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Bezawork-Geleta, Ayenachew $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Sobol, Margaryta $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

700    1_

$a Filimonenko, Anatoly $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

700    1_

$a Tomasetti, Marco $u Department of Molecular and Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

700    1_

$a Zobalová, Renata $u School of Medical Science, Griffith University, Southport, Queensland, Australia; Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0310352

700    1_

$a Hozák, Pavel, $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $d 1958- $7 js20040517003

700    1_

$a Dong, Lan-Feng $u School of Medical Science, Griffith University, Southport, Queensland, Australia.

700    1_

$a Neužil, Jiří, $u School of Medical Science, Griffith University, Southport, Queensland, Australia; Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $d 1958- $7 xx0115772

773    0_

$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 5 (2015), s. e0119549

856    41

$u https://pubmed.ncbi.nlm.nih.gov/25932953 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20160408 $b ABA008

991    __

$a 20231121141119 $b ABA008

999    __

$a ok $b bmc $g 1113672 $s 934611

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 10 $c 5 $d e0119549 $e 20150501 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950

GRA    __

$a NT13112 $p MZ0

GRA    __

$a NT14078 $p MZ0

LZP    __

$a Pubmed-20160408